| Vaccines |
1 |
1 |
| Influenza |
0 |
0.9 |
| Immunization |
0 |
0.79 |
| Influenza Vaccine |
0 |
0.67 |
| Human Papillomavirus |
0 |
0.56 |
| Clinical Guidelines |
0 |
0.55 |
| Biologic Therapy |
0 |
0.49 |
| Treatment Guidelines |
0 |
0.41 |
| Disease-Modifying Antirheumatic Drugs |
0 |
0.22 |
| Rheumatoid Arthritis |
0 |
0.99 |
| Child |
0 |
0.17 |
| COVID-19 |
0 |
0.13 |
| Diarrhea |
0 |
0.13 |
| Pain Management |
0 |
0.13 |
| Immunosuppressive Therapy |
0 |
0.1 |
| Pregnancy |
0 |
0.08 |
| New York |
0 |
0.07 |
| Varicella-Zoster Virus |
0 |
0.07 |
| Adolescent Medicine |
0 |
0.05 |
| Hospital |
0 |
0.05 |
| Oregon |
0 |
0.05 |
| Surgery |
0 |
0.05 |
| HPV Vaccine |
0 |
0.04 |
| Antigens |
0 |
0.02 |
| Antineoplastic Drug |
0 |
0.02 |
| Birth |
0 |
0.02 |
| Epidemiology |
0 |
0.02 |
| Fellowship |
0 |
0.02 |
| Geriatrics |
0 |
0.02 |
| Monoclonal Antibody |
0 |
0.02 |
| Nonsteroidal Anti-Inflammatory Agents |
0 |
0.02 |
| Papillomavirus |
0 |
0.02 |
| Pneumococcal Infection |
0 |
0.02 |
| Rheumatic Disease |
0 |
0.02 |
| Rotavirus |
0 |
0.02 |